Middle East and Africa Botulinum Toxin Market is expected to reach US$ 453.55 million by 2030

Specialty and Dermatology Clinics Held Largest Share of Middle East and Africa Botulinum Toxin Market in 2022

According to our new research study on “Middle East and Africa Botulinum Toxin Market Forecast to 2030 – Regional Analysis – by Product, Application, End User, and Region,” the Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to record a CAGR of 12.8% from 2022 to 2030. 

Based on product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport Xeomin, and others. The Botox segment held the largest market share in 2022 and is expected to retain its dominance during the forecast period. By application, the market is bifurcated into medical and aesthetic. The medical segment held a larger market share in 2022. However, the aesthetic segment is anticipated to register a higher CAGR during the forecast period. The Middle East and Africa botulinum toxin market, in terms of end user, is segmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2022, and it is anticipated to record the highest CAGR in the market during the forecast period. Growing preference for noninvasive cosmetic procedures propels the popularity of Botox treatments at dermatology clinics. Botox is a form of botulinum toxin, and it is commonly used in dermatology clinics to reduce the appearance of facial wrinkles and fine lines. Specialty and dermatology clinics often offer personalized treatment plans, tailoring Botox injections to meet individual aesthetic goals. Also, the rising popularity of cosmetic procedures such as Botox treatments, laser therapies, and facial rejuvenation has led to the expansion of dermatology clinics in the Middle East and Africa.

Based on country, the Middle East and Africa botulinum toxin market is segmented into Saudi Arabia, the UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East and Africa. Saudi Arabia held the largest market share, whereas the market in the UAE is expected to witness the fastest growth during the forecast period. UAE’s increasing number of aesthetic procedures propels the market growth. As per the Dubai Health Statistics published in 2021, the total number of aesthetic procedures performed in skin care clinics in the private sector in Dubai reached 583,909 in 2021 compared to 223,507 in 2020. Moreover, as per the Dubai Health Authority statistics published in 2021, 8,530 botox procedures were performed in the UAE in 2021, out of which 1,139 procedures were performed on males and 7,391 on females. Additionally, Dubai Health Authority statistics for 2020 reported that Botox is one of the most common skin care treatments performed in the UAE and occupied nearly 10.6% of skin care procedures in 2020. Thus, rising number of botulinum toxin procedures fuels the Middle East & Africa botulinum toxin market growth.

Growing disposable incomes in the Middle East & Africa, rising awareness regarding the benefits of botulinum toxin,  growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases drive the Middle East and Africa botulinum toxin market growth. The market is also expected to benefit from the development of new and innovative botulinum toxin products and applications. In January 2023, Korea-based Medytox, a biopharmaceutical company, signed a memorandum of understanding (MoU) with Dubai Science Park to build a botulinum toxin production facility in the UAE, seeking to capitalize on the country's fast-growing market for cosmetic products.

Side effects associated with the botulinum toxin hamper the Middle East and Africa botulinum toxin market growth.

Abbvie Inc.; Merz Aesthetics; Galderma; Evolus; Revance Therapeutics Inc.; Ipsen SA; Medytox Inc.; Evolus Inc.; Hugel Inc.; Lanzhou Institute of Biological Products Co Ltd; Gufic; and Metabiologics, Inc. are among the key players in the Middle East and Africa botulinum toxin market. These companies invest heavily in research and development to develop new and innovative botulinum toxin products and applications. They are also expanding their presence in the Middle East market by establishing joint ventures and partnerships with local companies. The factors mentioned above are expected to fuel the market growth. The market is also expected to benefit from the development of new and innovative botulinum toxin products and applications.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com